Skip to search formSkip to main contentSkip to account menu

leukemia relapse

Known as: Unspecified leukemia, in relapse, leukemia relapses, relapse leukemia 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study.
Review
2014
Review
2014
The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea
BackgroundPrimaquine is the only drug available for preventing relapse following a primary attack by Plasmodium vivax malaria… 
2014
2014
Lacosamide efficacy in epileptic syndromes with continuous spike and waves during slow sleep (CSWS)
Review
2009
Review
2009
Second-line treatment paradigms for diffuse large B-cell lymphomas
Despite recent major advances in treating diffuse large B-cell lymphoma with dose-intense regimens and the addition of the anti… 
Highly Cited
2003
Highly Cited
2003
Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy.
1997
1997
The effect of intrathecal MBP synthetic peptides containing epitope P85VVHFFKNIVTP96 on free anti-MBP levels in acute relapsing multiple sclerosis
Review
1996
Review
1996
Hepatic fascioliasis: case report and review.
A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical… 
1992
1992
[The surgical therapy of equine recurrent uveitis].
Equine recurrent uveitis (ERU) is the most frequently encountered cause of eye problems and blindness in horses. Classic… 
1992
1992
Recurrent tinea pedis: a double blind study on the prophylactic use of fenticonazole powder *
Summary. Tinea pedis is a common and frequently recurring dermatophytic infection, which is extremely difficult to eradicate. The… 
1989
1989
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)